Sulforaphane as an anticancer molecule: mechanisms of action, synergistic effects, enhancement of drug safety, and delivery systems
Kamal Mohammad M., Akter Sharmin, Lin Chin-Nu, Nazzal Sami,
소속 상세정보
( Kamal Mohammad M. )
University of Louisiana Monroe College of Pharmacy School of Basic Pharmaceutical and Toxicological Sciences
( Akter Sharmin )
Shaheed Ziaur Rahman Medical College Hospital
( Lin Chin-Nu )
Texas Woman’s University College of Nursing
( Nazzal Sami )
Texas Tech University Health Sciences Center School of Pharmacy Department of Pharmaceutical Sciences
Abstract
Sulforaphane is an isothiocyanate compound that has been derived from cruciferous vegetables. It was shown in numerous studies to be active against multiple cancer types including pancreatic, prostate, breast, lung, cervical, and colorectal cancers. Sulforaphane exerts its therapeutics action by a variety of mechanisms, such as by detoxifying carcinogens and oxidants through blockage of phase I metabolic enzymes, and by arresting cell cycle in the G2/M and G1 phase to inhibit cell proliferation. The most striking observation was the ability of sulforaphane to potentiate the activity of several classes of anticancer agents including paclitaxel, docetaxel, and gemcitabine through additive and synergistic effects. Although a good number of reviews have reported on the mechanisms by which sulforaphane exerts its anticancer activity, a comprehensive review on the synergistic effect of sulforaphane and its delivery strategies is lacking. Therefore, the aim of the current review was to provide a summary of the studies that have been reported on the activity enhancement effect of sulforaphane in combination with other anticancer therapies. Also provided is a summary of the strategies that have been developed for the delivery of sulforaphane.
키워드
Cancer; Drug delivery systems; Sulforaphane; Combination therapy; Synergism; Isothiocyanates
원문 및 링크아웃 정보
등재저널 정보